Siemens Fonds Invest GmbH Buys 2,305 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Siemens Fonds Invest GmbH boosted its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 997.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,536 shares of the medical instruments supplier's stock after purchasing an additional 2,305 shares during the quarter. Siemens Fonds Invest GmbH's holdings in Mettler-Toledo International were worth $3,103,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Barclays PLC boosted its holdings in Mettler-Toledo International by 8.3% during the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier's stock worth $384,822,000 after acquiring an additional 19,609 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock worth $332,634,000 after acquiring an additional 28,478 shares during the last quarter. Fifth Third Bancorp boosted its holdings in Mettler-Toledo International by 7.6% during the 4th quarter. Fifth Third Bancorp now owns 878 shares of the medical instruments supplier's stock worth $1,074,000 after acquiring an additional 62 shares during the last quarter. Blue Trust Inc. boosted its holdings in Mettler-Toledo International by 70.8% during the 4th quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier's stock worth $50,000 after acquiring an additional 17 shares during the last quarter. Finally, Union Bancaire Privee UBP SA purchased a new position in Mettler-Toledo International during the 4th quarter worth $1,616,000. Institutional investors and hedge funds own 95.07% of the company's stock.

Mettler-Toledo International Price Performance

MTD stock traded down $16.85 during mid-day trading on Friday, reaching $1,156.33. 317,154 shares of the company traded hands, compared to its average volume of 150,406. The company has a market capitalization of $24.03 billion, a P/E ratio of 28.53, a P/E/G ratio of 3.30 and a beta of 1.40. Mettler-Toledo International Inc. has a 52-week low of $946.69 and a 52-week high of $1,546.93. The company has a fifty day moving average price of $1,093.82 and a 200-day moving average price of $1,205.75.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The business had revenue of $883.74 million during the quarter, compared to analyst estimates of $876.61 million. During the same quarter in the previous year, the firm earned $8.89 EPS. The company's quarterly revenue was down 4.6% compared to the same quarter last year. As a group, analysts forecast that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Wall Street Zen downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Robert W. Baird lowered their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a research note on Monday, April 7th. Evercore ISI lifted their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research note on Monday, February 10th. Finally, UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their target price for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Seven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $1,302.11.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the sale, the director now owns 120 shares of the company's stock, valued at $139,191.60. This represents a 89.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.